Background: Observational studies have suggested that sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with a lower risk of atrial fibrillation (AF) recurrence after catheter ablation ...
Background and Aim: The aim of this retrospective study was to examine the relationship between diabetes mellitus and recurrence of hepatocellular carcinoma after potentially curative therapy for ...
Following ablation for AF, GLP-1 agonist therapy is associated with decreased risk for AF recurrence in patients with type 2 diabetes. Glucagon-like peptide-1 receptor (GLP-1) agonist use is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback